Why Is Tonix Pharmaceuticals (TNXP) Stock Up 30% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
TNXP stock is rallying because Tonix received a patent for its potential monkeypox vaccine and broader Recombinant Pox Virus platform.
The post Why Is Tonix Pharmaceuticals (TNXP) Stock Up 30% Today? appeared first on InvestorPlace.
More From InvestorPlace